Fighting for air. by unknown
Since we have no choice butto be swept along by[this]vasttechnological surge, we might as well learn to surf.
Michael Soule
Conservation forthe21stCentury
(D. Western and M.C. Pearl)
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Rethinking
Thalidomide
New research indicates
that the controversial
drug thalidomide, which
caused severe birth defor-
mities when taken as a
sedative and hypnotic by
pregnant women in the
1960s, may be useful in
treating diseases that
cause blindness.
Robert D'Amato, a
researcher at the Child-
ren's Hospital at Harvard
Medical School, came
across thalidomide while
searching for drugs to
treat two diseases that
cause blindness, macular
degeneration and diabetic
retinopathy. Both dis-
eases cause excess growth of blood vessels
which burst in the eye and destroyvision.
D'Amato, an ophthalmologist with a
Ph.D. in neuroscience, said that in looking
for a drug that stops blood vessel growth,
or an angiogenesis inhibitor, he realized
such a drug would have left a trail ofclues.
It occurred to him that an angiogenesis
inhibitor would cause menstrual periods to
stop, as well as cause birth defects. He con-
ducted a medical literature search for drugs
that caused these side effects, and hit upon
thalidomide. "Thalidomide was one drug
that fit the profile, because it had the
appropriate side effects for an angiogenesis
inhibitor," he said.
D'Amato theorized that the reason
thalidomide causes birth defects is that it
acts during angiogenesis to affect blood
vessels offetuses. He said that for 30 years,
scientists had been trying to figure out
how thalidomide affects fetuses, but no
one had studied blood vessels. It has only
been in the last 10 years that scientists have
been able to grow blood vessels in cultures
to study them. D'Amato set out to prove
that thalidomide is indeed an angiogenesis
inhibitor, and as such may present a possi-
ble treatment for macular degeneration
and diabetic retinopathy.
Diabetic retinopathy results from high
blood sugar levels that lead to a scarcity of
blood in the retina. To compensate, the
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Eyes on thalidomide. New research suggests the drug may be used to treat diseases such as
maculardegeneration.
retina produces factors that encourage
blood vessels to grow into a tangled mass,
interfering with vision. The disease can be
treated with lasers, which burn away the
excess vessels, but only if the vessels
haven't reached the retina.
Macular degeneration, which mostly
affects people over the age of 65, results
from a blood vessel growing under the
macula, the center ofthe retina, that blocks
vision. Some cases can be alleviated by
treating the blood vessel from the side with
a laser, but the process still affects vision.
D'Amato teamed up with Michael
Loughnan, an Australian ophthalmologist,
to test thalidomide on rabbits. They surgi-
cally implanted a substance that encour-
ages blood-vessel growth in a pocket ofthe
rabbits' corneas, causing a stream ofvessels
to grow across the cornea. The researchers
then administered thalidomide and various
compounds ofthalidomide orally, to see if
any of the drugs could halt the blood-ves-
sel growth. The only successful com-
pounds were the ones that inhibited blood
vessel growth and caused birth defects,
thus supporting D'Amato's theory.
D'Amato said that thalidomide alone
worked the best to halt blood vessel
growth. The eyes of the rabbits that were
given thalidomide had only a scattering of
blood vessels around the growth pocket.
Since this discovery in December
1992, the researchers
have conducted tests on
mice and found similar
results. The FDA grant-
ed D'Amato approval for
clinical trials to begin in
January 1995. The re-
searchers will test men
and postmenopausal
women with macular
degeneration. D'Amato
said results will not be
seen for at least a year. If
the tests prove successful,
however, a widespread
treatment for macular
degeneration would most
likely be available around
January 1996.
And, if the tests go
well, the researchers
would then begin testing
thalidomide for treatment of diabetic
retinopathy. However, D'Amato said they
would first test diabetic men only. If suc-
cess is seen in the male diabetics, they will
begin testing women. D'Amato said, "If
we were going to use thalidomide in pre-
menopausal women, we would have to be
assured that they wouldn't get pregnant."
D'Amato said the reaction to the new
therapy has been tremendous. "The idea of
taking a pill to relieve this is novel," he
said.
Fighting for Air
Air pollution must be turned into the pub-
lic nemesis that cigarette smoking has
become. This underlying tenet from a con-
ference sponsored by the National Assoc-
iation of Physicians for the Environment
(NAPE) on November 18 will be devel-
oped into a major public education cam-
paign targeting both the scientific commu-
nity and the public.
In fact, much ofthe material for NAPE's
anti-air pollution campaign will be drawn
from the November conference detailing the
impact ofair pollution on body organs and
systems. During that conference, scientific
experts warned that lack ofovert symptoms
does not mean lack ofadverse effects, and
that the ravages ofair pollution are not lim-
ited to the respiratory tract. "It's not just the
132 Environmental Health Perspectiveslungs and lower respiratory tract, but also
the eyes, the ears, the nose, and the skin that
are exposed to environmental pollution,"
noted conference chair G. Richard Holt,
who is also chair of NAPE's air pollution
committee. Hearing loss, for example, may
be linked to toxic materials such as heavy
metals, and exposure to certain hydrocar-
bons can lead to smell and taste dysfunction.
High levels ofozone and other air pollutants
can result in both cancerous and noncancer-
ous mucosal lesions. Humans are climbing
up the ladder leading to severe physical
effects from air pollution, warned Richard
Trevino, president of the American
Academy of Otolaryngic Allergy, and the
absence ofidentifiable symptoms should not
be asource ofcomfort.
Conference speakers were unanimous
in calling for more research into the
adverse effects of air pollution-both sub-
tle and direct-and in urging the medical
profession to become more attuned to the
possibility of pollution as the cause of
patient distress. Trevino, for example, said
he believes air pollution is directly respon-
sible for the rising incidence of hay fever,
not only irritating the nasal mucosa but
also making people more susceptible to
allergens and toxicants. Data have been
collected from numerous sites linking
increased asthma incidence with rises in
ground-level ozone concentrations.
The effects of air pollution are often
hidden, insidious, and long-term, speakers
pointed out during the conference. Lowell
Goldsmith, chair of the American
Academy of Dermatology's Environment
Committee, said even the morning shower
is not risk-free. Goldsmith has calculated
that showering with chlorinated water
leads to inhalation of chloroform, which
causes cancer in animals, at levels that
exceed current EPA standards. Fortunately,
he added, most people don't spend extend-
ed periods of time showering. Air pollu-
tants may also be absorbed by the body
and recycled, in essence, later in life. Joan
McGowan, chief of the bone biology and
bone diseases branch of the National
Institute ofArthritis and Musculoskeletal
and Skin Diseases, reported that as women
enter menopause, the process of bone
remodeling in which calcium and minerals
are released by bone speeds up. Along with
calcium, heavy metals such as lead that
have been stored in bone may also be
released by bone back into bodysystems.
A major concern ofthe conference was
the effect ofair pollution on special popula-
tions such as women, the poor, minorities,
and children-populations often ignored in
research. Citing a need for environmental
justice, NIEHS Director Kenneth Olden
said the institute has commissioned special
studies to focus on health problems among
the poor that might be linked to air pollu-
tion. The poor, he noted, tend to live in
inner-city areas where pollutants are con-
centrated or work in argicultural areas
where direct exposure to pesticides, herbi-
cides, and fertilizers is prevalent.
Terri Damstra, associate director for
international programs at NIEHS, pointed
out that toxins which imitate estrogens,
such as DDT, dioxin, and PCBs, are ubiq-
uitous in the environment. These com-
pounds, which have been associated with
cancers and with breast, uterine, and bone
disease, are disbursed in the atmosphere
and subsequently enter the food chain.
Damstra said 90% of the PCBs in the
Great Lakes come directly from
the atmosphere. Kathy Bryant,
associate director of government
relations for the American
College of Obstetricians and
Gynecologists, noted that these
estrogen imitators are stored pri-
marily in fat, and may have a
disproportionate effect on
women because women natural-
ly have higher percentages of
body fat than do men. Bryant
called for an interagency review
at the federal level to examine
risk-assessment policy and its
impact on women's health.
Animals and plants are not spared
the devastating effects of pollution,
according to one session at the con-
ference. Acid rain, ground-level
ozone concentrations, and
other ambient air toxins
are depleting the
world of 50,000
plant species annu-
ally, destroying
nature's ecological
balance and narrow-
ing forever the array of
plants that might produce
beneficial pharmaceuticals,
warned Christopher T. Moore, chair of
the environmental council of the
Wilderness Medical Society. Air pollution
knows no political boundaries, Moore
pointed out, and even the most pristine
areas show signs ofenvironmental distress.
Included in the NAPE campaign's arse-
nal will be white papers, "scientific posi-
tion" papers and educational videos that
describe the impact ofair pollution on each
body organ and system. "The same tools
that were used successfully against cigarette
smoking-research, public health educa-
tion, and advocacy-can be used against air
pollution," urged conference co-chair
Alfred Munzer, former president of the
American LungAssociation.
NAPE, organized just two years ago,
has grown to include dozens of medical
and environmental organizations, as has
the worldwide affiliate it helped to orga-
nize, the International Society of Doctors
for the Environment. In April NAPE will
sponsor a conference on biodiversity loss,
and subsequent plans include a conference
addressing the impact of water pollution
on body organs that parallels the air pollu-
tion conference.
Safe to Eat
Last September, the U.S. General
Accounting Office released two reports
that called for restructuring the federal
food safety system. The reports cited
extensive problems with the
current system of monitor-
ing amounts of unsafe
chemical residues and envi-
ronmental contaminants in
food. Among GAO's find-
ings are inconsisten-
cies in assessing chem-
ical risks and lack of
prosecutions for viola-
tions of chemical lim-
its in food.
TheFDA,theUSDA,
and the EPA all share
the responsibility for
monitoring chemicals
that enter the food
supply. These include
chemical residues that
w
Food feud. Two GAO reports call for restructur-
ing the federal food safety system, but industry
disputesthe findings.
result from the use of pesticides, animal
drugs, and food additives, as well as envi-
ronmental contaminants, such as lead and
mercury, that enter the food supply
through their occurrence in the environ-
ment, naturally or as a result ofpollution.
The agencies' responsibilities include
approving food-use chemicals before they
can be used; sampling and testing food
products to ensure their safety, or end-
product testing; and taking regulatory
actions when violations occur.
The GAO examined the federal pro-
grams and identified several fundamental
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